C NMR spectra were recorded on a Bruker AV400 (101 MHz) spectrometer using the PENDANT or DEPT Q pulse sequences with broadband proton decoupling and internal deuterium lock. The chemical shift data for each signal are given as  in units of parts per million (ppm) relative to tetramethylsilane (TMS) where C (TMS) = 0.00 ppm. 1 H and 13 C spectra were assigned using 2D NMR experiments including COSY and HSQC.
Mass spectra were acquired on Agilent technologies 6120 quadruple LC/MS spectrometer using electrospray ionisation, operating in positive or negative mode, from sample solutions in MeOH. m/z values are reported in Daltons and followed by their percentage abundance in parentheses. High resolution mass spectra (HRMS) were recorded using Bruker MicroTOF internally calibrated with polyalanine. 1 H NMR and HRMS spectra are presented in Figure S9 .
Synthetic Procedures and Characterisation for Compounds


8-Hydroxyquinoline-5-carboxylic acid (1)
Acrolein (550 mg, 0.65 mL, 9.81 mmol, 1.5 eq.) was added dropwise over 30 min to a solution of 3-amino-4-hydroxybenzoic acid (1.0 g, 6.54 mmol, 1.0 eq.) in 6 N HCl. The reaction mixture was refluxed at 100°C for 2 h in a 50 mL round bottom flask fitted with a jacketed water condenser. Upon completion of the reaction based on TLC analysis, the reaction mixture was allowed to cool to room temperature and the pH was adjusted to pH 9 with aqueous ammonia. The mixture was then filtered and the filtrate was acidified to pH 4-5 with 10% aqueous acetic acid. The resulting precipitate was obtained by filtration, washed with water (10 mL) and dried in vacuo to yield the desired product 1 as a brown powder (642 mg, 3.40 mmol, 52%). R f = 0.35 (CH 2 
Methyl 8-hydroxyquinolone-5-carboxylate (2)
To a mixture of 5-bromoquinolin-8-ol (4 g, 17.85 mmol), triphenylphosphine (9.37 g, 35.7 mmol) and 2-(trimethylsilyl)ethanol (3.82 mL, 26.8 mmol) in tetrahydrofuran (THF) (40 mL) and toluene (40 mL) was slowly added diisopropyl azodicarboxylate (DIAD) (7.40 mL, 35.7 mmol). The reaction mixture was then stirred at room temperature for 24 h. After completion of the reaction, the reaction mixture was concentrated and purified using a Biotage Flash system eluting with 25% EtOAc in hexanes to afford 5.1 g (5.1 g, 15.73 mmol, 88%) of 5-bromo-8-(2-(trimethylsilyl)ethoxy)quinoline as a colorless oil. To a degassed solution of 5-bromo-8-(2-(trimethylsilyl)ethoxy)quinoline (5.1 g, 15.73 mmol) in methanol (40 mL) and DMSO (40 mL) was added palladium(II)acetate (0.353 g, 1.57 mmol), 1,3-bis(diphenylphosphino)propane (1.30 g, 3.15 mmol) and Et 3 N (8.8 mL, 62.9 mmol). The reaction mixture was bubbled with carbon monoxide for 5 minutes then stirred under a carbon monoxide atmosphere (balloon pressure) for 16 h. The crude reaction mixture was then extracted twice with CH 2 Cl 2 . The organic layer was washed successively with water, ammonium chloride and brine. The crude product obtained upon concentration was purified using a Biotage Flash system eluting with 25% EtOAc in hexanes to afford colourless oil (4.6 g, 22.64 mmol, 96%). 1.3 g of the pure product was dissolved in 12 mL of CH 2 Cl 2 /CF 3 CO 2 H (1:1 by volume) mixture and heated in a Biotage microwave reactor at 100°C for 15 minutes to give 2. The solvent was evaporated off and the crude product was purified by preparative HPLC. 
n-Butyl 8-hydroxyquinoline-5-carboxylate (4)
A solution of 1 (100 mg, 0.53 mmol) in n-butanol (10 mL) and one drop of concentrated H 2 SO 4 was refluxed at 120°C for 21 h in a 50 mL round bottom flask fitted with a jacketed water condenser. Upon completion of the reaction, based on TLC analysis, the reaction mixture was neutralised with 20% aqueous NaOH and the excess n-butanol was removed in vacuo. The residue was dissolved in ethylacetate (EtOAc, 10 mL), washed with sat. NaHCO 3 (aq) (10 mL) and water (2 x 10 mL)), dried over 
n-Octyl 8-hydroxyquinoline-5-carboxylate (5)
A solution of 1 (100 mg, 0.53 mmol) in n-octanol (10 mL) and one drop of concentrated H 2 SO 4 was refluxed at 120°C for 20 h in a 50 mL round bottom flask fitted with a jacketed water condenser. Upon completion of the reaction based on TLC analysis, the reaction mixture was neutralised with 20% aqueous NaOH. Excess n-octanol was removed by rotary evaporation at 70°C and 15 mbar. The residue was further purified by flash silica gel chromatography (eluting with 6 column volumes of cHex followed by gradient elution with 0 to 100% CH 2 
Methyl 8-acetoxyquinolone-5-carboxylate (6)
A mixture of 2 (0.1 g, 0.492 mmol), 4-dimethylaminopyridine (DMAP) (0.012 g, 0.098 mmol) and acetic anhydride (0.232 mL, 2.461 mmol) in CH 2 Cl 2 (3 mL) was refluxed for 1 h. The reaction mixture was concentrated and purified using a Biotage Flash system eluting with 20% EtOAc in hexanes to afford compound 6 as a white solid. 
(Pivaloyloxy)methyl-8-((pivaloyloxy)methoxy)quinoline-5-carboxylate (7)
To a mixture of 1 (100 mg, 0.53 mmol, 1.0 eq.) and chloromethyl pivalate (77 µL, 0.53 mmol, 1.0 eq.) in a mixture of acetone / dimethylformamide (1:1, 10 mL) was added Et 3 N (54 mg, 0.53 mmol, 1.0 eq.). The mixture was refluxed at 50°C for 3 h, whereupon a small amount of precipitate was formed. The precipitate was filtered and washed with acetone (20 mL). The filtrate was evaporated and the residue was partitioned between 5% w/w aqueous NaHCO 3 (30 mL) and EtOAc (20 mL). The organic phase was collected, dried over MgSO 4 and concentrated in vacuo. The residue was further purified by flash silica gel chromatography (gradient elution of 0 to 40% EtOAc in cHex (15 column volumes) followed by 5 column volumes of 40% EtOAc in cHex) to give 7 as a yellow oil (52 mg, 0.13 mmol, 24%). R f = 0.45 (cHex / EtOAc (3:2)); 
Biological Procedures
Cell Culture
The human cervical carcinoma HeLa cell line was from the American Type Cultures Collection (ATCC, Manassas, VA) and cultured in Dulbecco's modified Eagle medium (DMEM; Invitrogen Gibco Cell Culture Products, Carlsbad, CA) supplemented with 10% FCS (Invitrogen), 1% Glutamax (Invitrogen) and 1% penicillin-streptomycin (Lonza). Cultures were kept at 37°C in a humidified atmosphere of 95% air and 5% CO 2 . Cells were detached from the culture flask with a solution of 0.05% trypsin and 0.02% Ethylenediaminetetraacetic acid (EDTA; Sigma) and then washed and suspended in complete culture medium with 10% FCS.
Viability analysis in HeLa cells
Antiproliferative activities of compounds were determined by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay. HeLa cells were seeded into 96-well plates (2000 cells/well) and cultured at 37°C for 24 h to achieve 70% confluency. Subsequently, the medium was replaced with DMEM medium containing the tested compounds in different concentrations of 1-300 M in 1% DMSO. Staurosporine in 0.03-10 M final concentration was used as a control for cytotoxicity. After 24 h of treatment, the medium was replaced with CellTiter 96® Aqueous One Solution Reagent (Promega) and incubated for 4 h. CC 50 values were calculated in Prism 6 software after normalisation against corresponding 1% DMSO treated cells and 1% DMSO in media (no cells) controls.
Cellular Demethylase Assay
A protocol adapted from that of King et al., 2010 was used for investigation of cell KDM inhibition activity. [2] HeLa cells were maintained in DMEM media supplemented with 10% FBS, penicillin and streptomycin. Cells were transiently transfected with either Flag-tagged KDM4A or the H188A catalytic inactive variant of KDM4A using Fugene HD. Inhibition studies were initiated 24 h after cellular transfection and compounds were added to a final concentration of 1-300 M in 1% DMSO. H3K9me3 levels were measured in cells following 24 h incubation with compound. All cells were stained with an anti-Flag mouse monoclonal antibody (Sigma F1804), rabbit anti-H3K9me3 (Abcam Ab8898) and DAPI (Sigma D9564) for DNA. Alexa Fluor® 488 antibody (Life technologies A-21121) and Alexa Fluor® 568 antibody (Life technologies A-11011) were used to fluorescently label the Flag and H3K9me3 primary antibodies. Image acquisition was conducted using Operetta High Content Imaging System (PerkinElmer) and image analysis was performed with Harmony High Content Imaging and Analysis Software (PerkinElmer). The nuclei were automatically identified by DAPI staining using the default parameters. Cells expressing low amounts of the exogenous demethylase, where Flag-tag staining was dim, were omitted from analysis by setting a minimum threshold. EC 50 values were calculated in Prism 6 after normalisation by setting DMSO treated KDM4A transfected cells to 100% demethylase activity and the catalytic inactive KDM4A variant transfected cells to 0% activity.
AlphaScreen Assay
A protocol adapted from that of Kawamura et al., 2010 was used. [3] All reagents were diluted in 50 mM HEPES, 0.1% BSA, pH 7.5 supplemented with 0.01% Tween20 and allowed to equilibrate to room temperature prior to addition to plates. Catalytic turnover assays were run in 10 µL volumes in lowvolume 384-well plates (ProxiPlateTM-384 Plus, PerkinElmer, USA) at RT. The reaction consisted of enzyme (5 nM), biotinylated substrate peptide (30 nM), Fe(II) (1 µM), ascorbate (100 µM), 2OG (10 µM) and run at RT. For PHD2, the reaction consisted of enzyme (5 nM), biotinylated substrate peptide (60nM), Fe(II) (20 M), ascorbate (200 M), 2OG (2 M) and run at RT. [4] EDTA was used to quench the reaction (5 µL), AlphaScreen donor (Streptavidin-conjugated) and acceptor (Protein A-conjugated) beads preincubated with peptide product antibodies were added (5 µL). Plates were foil-sealed to protect from light, incubated at room temperature for 60 minutes and read on a PHERAstar FS plate reader (BMG Labtech, Germany) using an AlphaScreen 680 excitation/570 emission filter set. The final bead concentration in 20 µL reaction was 20 µg/mL. IC 50 values were calculated in Prism 6 after normalisation against corresponding DMSO controls.
Test of Compound Stability in the AlphaScreen
Buffer 3 mM of the tested compounds were incubated in a solution composed of AlphaScreen buffer (50 mM HEPES pH 7.5 supplemented with 0.1% BSA, 0.01% Tween20, Fe(II) (10 µM), ascorbate (100µM) and 2OG (10 µM)) in room temperature. Samples were taken for LCMS analysis after 0, 1, 2 and 24 h of incubation. LCMS retention times (t r ) are quoted to the nearest 0.1 min. LCMS was performed on a WATERS Sunfire equipped with a C18 column (150 mm x 4.6 mm, 5 µm) using a linear gradient of solvent A (water + 0.1% CF 3 CO 2 H) and solvent B (acetonitrile + 0.1% CF 3 CO 2 H), eluting at a flow rate of 1 mL/min and monitoring at 254 nm: 2% B over 2 min, 2% B to 100% B over 16 min and 100% B over 2 min.
Intracellular Delivery Assay
The protocol used was adapted from that of Kruidenier et al., 2010 . [5] HeLa cells were dosed with 200 µM IOX1 1, n-octyl ester 5 or DMSO. After 24 h of incubation the media was aspirated and the cells were washed with PBS. The number of cells in each sample was determined. Extraction of the compounds from the cells was performed by lysis using 80% aqueous methanol. All samples were shaken for 10 min on a vortex mixer and then centrifuged for 10 min at 15000 rpm. The supernatant was removed and the methanol solution was evaporated using a SpeedVac machine. Samples were dissolved with water in proportion to the cell count and an aliquot of the resulting supernatant was mixed with caffeine at 1000 ng/mL as the internal standard. Samples were analysed by reverse phase LC MS/MS using a heat assisted electrospray interface in positive ion mode. The instrument used was a Waters Quattro Micro triple quadrupole mass spectrometer coupled to liquid chromatrography CTC PAL and Waters Acquiy UPLC. The column was Gemini C18 HPLC with 3.0 mm internal diameter (Phenomenex). Nominal MRM (Multiple Reaction Monitoring) transitions for analytes were 190.0 to 146.0 for IOX1 1, 302.2 to 190.0 for ester 5 and 195.0 to 138.1 for Caffeine. MRM methods were ran over a 5 minutes gradient running from 1% ACN + 0.5% acetic acid (aq) to 90% ACN + 10% formic acid (aq), held for 2 minutes and returned to the starting conditions over 0.1 minutes and remained at the starting conditions for 3 minutes. Samples were assayed against calibration standard curve over the range of 0 to 200 M prepared with diluted cell lysate of cells dosed with DMSO. Quantitative analysis was made by measuring the peak area of the compounds, normalised using caffeine, followed by linear regression analysis to calculate the number of moles per cell ( Figure S3 ).
Cell culture and immunoblotting for HIF hydroxylase inhibition assay
Cells (Hep3B, RCC4 and HeLa) were cultured in DMEM each supplemented with 10% fetal calf serum, 2 mM L-glutamine, 50 units/ml of penicillin, and 50 g/ml of streptomycin. Cells were treated with compounds for 5-6 h and harvested for immunoblotting as previously described. [6] All compounds (except DMOG) were dissolved in DMSO and added directly to culture medium at final DMSO concentrations of ≤2%. DMOG (dimethyloxalylglycine, dissolved in water) and FG2216 were used as positive controls. MG132 treatment was for 4 h. Antibodies to HIF-1 and -actin/HRP were from BD Transduction Laboratories (clone-54) and Abcam (clone, AC-15) respectively and an antibody to hydroxyAsn803 (HyAsn803) was a kind gift from Dr Myung Kyu Lee (BioNanotechnology Research Centre, KRIBB, Republic of Korea).
Docking experiments
For protein-ligand docking simulations, an X-ray crystal structure of KDM4A in complex with IOX1 (PDB ID -3NJY) was employed. [2] Attention was paid to the assignment of protonation states for Asp, Glu, His and Lys residues. Atomic charges were then assigned to the all-atom model of KDM4A through the restrained electrostatic potential (RESP) methods using the AMBER program. Due to the need for electronic charge redistribution resulting from the ferrous ion and its ligands, quantum mechanical calculation was performed at the PBE0/6-31** level of theory with geometry optimization for a simplified model of ferrous ion in complex with the amino acid residues and the posed ligand IOX1. [7, 8] The calculated RESP atomic charges of the active site ferrous ion and its ligand atoms in the KDM4A-IOX1 complex model were as follows (in e): Fe: +1.087, His188 NE: -0.292, His276 NE: -0.213, Glu190 OD: -0.630, IOX1 NAC: -0.592, IOX1 OAN: -0.587. This calculation indicates that the atomic charge of the ferrous ion decreases from +2.000 to +1.087 e upon the formation of the inhibitor complex. The assigned RESP charges of the nitrogen atoms of the two histidine residues are -0.292 and -0.213 respectively; the oxygen of Glu, the nitrogen of IOX1 and the phenolic oxygen of IOX1 are assigned charges -0.630, -0.592 and -0.587 respectively, similar to the values calculated in the absence of the ferrous ion. These changes reflect the redistribution of charges between the ferrous ion and its ligand atoms during the formation of the metal complex.
The RESP partial charges for the atoms detailed above were recalculated for each of the IOX1 ester derivatives based on the calculation done for IOX1. For the docking simulations of each of the IOX1 ester derivatives, the empirical AutoDock scoring function was used, improved by the implementation of a new solvation model for each compound. [9] The modified scoring function has the following form: 

Where W vdW , W hbond , W elec , W tor , and W sol are the weighting factors of van der Waals, hydrogen bond, electrostatic interactions, torsional term and desolvation energy of the inhibitors, respectively. r ij represents the interatomic distance and A ij , B ij , C ij , and D ij are related to the depths of the potential energy well and the equilibrium separations between two atoms. The hydrogen bond term has an additional weighting factor, E(t), representing the angle-dependent directionality. A cubic equation approach was applied to obtain the dielectric constant required to compute the interatomic electrostatic interactions between KDM4A and 5. In entropic terms, N tor is the number of sp 3 bonds in the ligand. In desolvation terms, S i , P i and V i are the solvation parameters, self-solvation parameter and the fragmental volume of atom i, respectively, while Occ i max is the maximum atomic occupancy. [10, 11] 
Supplementary Figures
Figure S1
HeLa Cell viability analysis after dosing with IOX1 ester derivatives
Figure S2
Analysis of H3K9me3 demethylation inhibition using immunofluorescence assays
Figure S3
Normalised calibration curves used to determine the intracellular levels of compounds by linear regression
Figure S4
Effects of IOX1 and IOX1 ester derivatives on HIF in human cell lines Table 1 . Values are mean ± SE. The procedure for this assay is described in the biological procedures section. Normalised calibration curves used to determine predicted intracellular levels of 1 and 5 by linear regression. Y axis: Moles of compound in the sample. X axis: Chromatogram peak area normalised by the peak area of the caffeine internal standard.
Calibration curve for the n-octyl ester 5.
12
Normalised calibration curves used to determine predicted intracellular levels . Y axis: Moles of compound in the sample. X axis: Chromatogram peak area normalised by the peak area of the caffeine internal standard. a) Note that 4 and 5 are both more active than IOX1 1, consistent with improved cell-penetration. A generic 2OG oxygenase inhibitor (DMOG/dimethyloxalylglycine), and PHD inhibitors (FG2216 and IOX2) were used as positive controls. [4] Note that the inhibition of HIF-1 asparaginyl hydroxylation was also observed implying the inhibition of factor inhibiting HIF (FIH) activity in cells. LE -long exposure. Table 1 . Values are mean ± SD, n=4. The procedure for the AlphaScreen assay is described in the biological procedures section. Measurements of the stability of IOX1 1 and n-octyl ester buffer by LCMS. mAU: milliabsorbance units. X axis: time in minutes. Average for observed species are: a) AlphaScreen buffer (50 mM HEPES pH 7.5 BSA, 0.01% Tween20, Fe(II) (10 µM), ascorbate (100µM) and 2OG = 2.0 and 8.5 minutes; b) IOX1 1 in AlphaScreen buffer in AlphaScreen buffer, R t = 14.8 minutes. The procedure for is described in the biological procedures section.
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